Financial reports
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
24 Feb 22
10-Q
2021 Q3
Quarterly report
4 Nov 21
Current reports
8-K
Amendments to Articles of Incorporation or Bylaws
8 Mar 24
8-K
Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
22 Feb 24
8-K
Immunic, Inc. Announces Private Placement of up to $240 Million
5 Jan 24
8-K
Departure of Directors or Certain Officers
21 Dec 23
8-K
Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update
14 Nov 23
8-K
Entry into a Material Definitive Agreement
18 Oct 23
8-K
Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis
10 Oct 23
8-K
Immunic, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
30 Jun 23
8-K
Immunic, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
11 May 23
Registration and prospectus
S-3/A
Shelf registration (amended)
1 Mar 24
S-3
Shelf registration
13 Feb 24
D
Exempt offering of security
19 Jan 24
S-3
Shelf registration
22 Nov 23
S-8
Registration of securities for employees
21 Aug 23
424B3
Prospectus supplement
20 Dec 22
S-3
Shelf registration
9 Dec 22
D
$60.00 mm in equity / options / securities to be acquired, sold $60.00 mm, 14 investors
18 Oct 22
424B5
Prospectus supplement for primary offering
2 May 22
S-8
Registration of securities for employees
28 Jul 21
Proxies
DEF 14A
Definitive proxy
23 Apr 24
DEF 14A
Definitive proxy
5 Feb 24
PRE 14A
Preliminary proxy
24 Jan 24
DEF 14A
Definitive proxy
1 May 23
DEF 14A
Definitive proxy
27 Apr 22
DEF 14A
Definitive proxy
27 Apr 21
DEF 14A
Definitive proxy
29 Apr 20
DEF 14A
Definitive proxy
18 Jun 19
DEFA14A
Additional proxy soliciting materials
27 Mar 19
DEFA14A
Additional proxy soliciting materials
25 Mar 19
Other
EFFECT
Notice of effectiveness
21 Dec 22
CORRESP
Correspondence with SEC
16 Dec 22
UPLOAD
Letter from SEC
15 Dec 22
EFFECT
Notice of effectiveness
6 May 21
CORRESP
Correspondence with SEC
3 May 21
UPLOAD
Letter from SEC
22 Apr 21
EFFECT
Notice of effectiveness
25 Nov 20
CORRESP
Correspondence with SEC
20 Nov 20
UPLOAD
Letter from SEC
20 Nov 20
SEC STAFF
SEC staff action: Order
2 Mar 20